LeonaBio (LONA) Cash from Investing Activities (2019 - 2026)

LeonaBio (LONA) has 8 years of Cash from Investing Activities data on file, last reported at -$15.5 million in Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 111.4% year-over-year to -$15.5 million in Q1 2026; TTM through Mar 2026 was -$24.1 million, a 169.93% decrease from a year earlier, with the FY2025 full-year figure at -$15.9 million, down 128.99% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$15.5 million, down from -$14.6 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for LONA reached as high as $35.5 million in Q1 2023 and fell as low as -$15.5 million in Q1 2026.
• Historically, Cash from Investing Activities has averaged $10.4 million across 5 years, with a median of $13.0 million in 2024.
• Across the five-year window, Cash from Investing Activities surged 828.22% in 2023 and sank 420.55% in 2025, its largest moves.
• Year by year, Cash from Investing Activities stood at $24.6 million in 2022, then plunged by 74.07% to $6.4 million in 2023, then sank by 144.0% to -$2.8 million in 2024, then sank by 420.55% to -$14.6 million in 2025, then declined by 6.16% to -$15.5 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$15.5 million in Q1 2026, -$14.6 million in Q4 2025, and $5.7 million in Q3 2025.